Dr. Gymbro
←

#fat burner

1 article
A softly lit editorial flat-lay on a pale oat-colored linen surface, shot from slightly above in a wide landscape composition. On the left, a small cluster of fresh Coleus forskohlii plant sprigs with velvety, scalloped green leaves and a few delicate lavender-blue flowers lies beside a rustic ceramic bowl of fine, golden-brown powdered root extract. A wooden scoop rests in the powder. In the center, a minimalist amber glass dropper bottle and a few cream-colored capsules are spilled neatly onto the linen, with no readable labels or logos. On the right, a slim analog kitchen scale in matte white shows a small, subtle weight, and beside it a soft sage-green measuring tape is loosely coiled in a gentle curve, hinting at waist measurement. A small open notebook with blank cream pages and a thin brass pen suggests careful tracking, with a few abstract pencil tick marks and no legible text. Accents include a halved lemon, a glass of water with condensation, and a sprig of eucalyptus for a calm wellness feel. Natural morning window light enters from the upper left, casting long, soft, diffused shadows and warm highlights across the textures of linen, ceramic, glass, and leaves. The palette is muted and modern: sage green, warm cream, soft terracotta, honey amber, and touches of dusty lavender. Shallow depth of field gently blurs the far edges, with the focus on the center objects. The mood is calm, trustworthy, and quietly skeptical, like a high-end health and science magazine cover. It is clean and uncluttered, with generous negative space at the top for headline overlay. Photographic, high-resolution, with subtle film grain and true-to-life color.
nutrition

فورسکولین سوزان چربی: ۲ کیلوگرم در ۱۲ هفته — متوسط اما واقعی؟

BY DR. GYMBRO ·

فورسکولین سال‌ها به‌عنوان معجزه‌ساز سوزاندن چربی تبلیغ می‌شد؛ آیا آزمایش جدید ۲۰۲۶ شواهد واقعی ارائه می‌کند؟ در مطالعه‌ای با ۶۰ شرکت‌کنندهٔ اضافه وزن به‌مدت ۱۲ هفته، عصاره *Coleus forskohlii* به‌طور میانگین ۱.۹۳ کیلوگرم وزن و ۱.۸۳ سانتیمتر دور کمر را نسبت به دارونما کاهش داد و سطوح تری‌گلیسیدها و HDL را بهبود داد. ایمنی نیز مشابه بود. با این حال، پژوهش شبه‌تصادفی، نمونهٔ کوچکی دارد و توسط تولیدکننده انجام شده؛ لذا اثر آن در مقایسه با داروهای GLP‑1 محدود است.

This page is available in